Helius Medical Technologies, Inc. (HSDT)
- Previous Close
2.6600 - Open
3.5895 - Bid 2.7800 x 100
- Ask 2.8600 x 100
- Day's Range
2.3500 - 3.6100 - 52 Week Range
2.3500 - 14.4500 - Volume
12,231,388 - Avg. Volume
423,624 - Market Cap (intraday)
2.547M - Beta (5Y Monthly) 1.55
- PE Ratio (TTM)
-- - EPS (TTM)
-14.5600 - Earnings Date May 9, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
15.47
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
heliusmedical.comRecent News: HSDT
Performance Overview: HSDT
Trailing total returns as of 5/3/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HSDT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HSDT
Valuation Measures
Market Cap
2.55M
Enterprise Value
-2.58M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.71
Price/Book (mrq)
1.08
Enterprise Value/Revenue
-4.00
Enterprise Value/EBITDA
0.21
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-61.40%
Return on Equity (ttm)
-168.55%
Revenue (ttm)
644k
Net Income Avi to Common (ttm)
-8.85M
Diluted EPS (ttm)
-14.5600
Balance Sheet and Cash Flow
Total Cash (mrq)
5.18M
Total Debt/Equity (mrq)
2.43%
Levered Free Cash Flow (ttm)
-6.11M